The Genetics of Heart and Vascular Disease

Memo

During this 3 day CME course, experts in the field of cardiovascular genetics detail the important role of genetics, genomics, and pharmacogenetics in the diagnosis, risk stratification, and treatment of diseases affecting the heart and the blood vessels. Topics covered will include, Genetics Genomics 101, pharmacogenetics, polygenic risk scores, variant interpretation, the molecular autopsy, and the diagnostic, prognostic, and therapeutic implications of genetic testing for patients with congenital heart disease, long QT syndrome, Brugada syndrome, hypertrophic/dilated/arrhythmogenic cardiomyopathy, coronary heart disease, hyperlipidemias, heart failure, pulmonary hypertension, cardiac amyloid, and the aortopathies. Unique Features: Audience response system to enhance immediate feedback. Easy access to faculty members. One-on-one interaction. Efforts will be made to introduce the clinical applications using new technology, however, there is no hands-on experience provided. Self-assessment questions to gauge outcome. A special workshop will be conducted to analyze a genetic test report and to comment on the significance of genetic test results from your patients. URL:Tickets: https://go.evvnt.com/355103-1?pid=5569 Time: 7:00 am - 12:15 pm  Prices:Course Registration (MD, PhD, DO, PharmD): USD 600.0,Course Registration (Fellows in Training, PA, NP, RN, GC): USD 475.0 Venue Details: The Meritage Resort and Spa, 875 Bordeaux Way, Napa, 94558, United States